1. Home
  2. TNDM vs PTY Comparison

TNDM vs PTY Comparison

Compare TNDM & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNDM
    SELLHOLDBUYas of a day ago
  • PTY
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • TNDM 2006
  • PTY 2002
  • Country
  • TNDM United States
  • PTY United States
  • Employees
  • TNDM N/A
  • PTY N/A
  • Industry
  • TNDM Medical/Dental Instruments
  • PTY Investment Managers
  • Sector
  • TNDM Health Care
  • PTY Finance
  • Exchange
  • TNDM Nasdaq
  • PTY Nasdaq
  • Market Cap
  • TNDM 1.9B
  • PTY 2.3B
  • IPO Year
  • TNDM 2013
  • PTY N/A
  • Fundamental
  • Price
  • TNDM $35.91
  • PTY $14.32
  • Analyst Decision
  • TNDM Buy
  • PTY
  • Analyst Count
  • TNDM 16
  • PTY 0
  • Target Price
  • TNDM $52.06
  • PTY N/A
  • AVG Volume (30 Days)
  • TNDM 1.2M
  • PTY 550.4K
  • Earning Date
  • TNDM 02-19-2025
  • PTY 01-01-0001
  • Dividend Yield
  • TNDM N/A
  • PTY 9.65%
  • EPS Growth
  • TNDM N/A
  • PTY N/A
  • EPS
  • TNDM N/A
  • PTY N/A
  • Revenue
  • TNDM $854,351,000.00
  • PTY N/A
  • Revenue This Year
  • TNDM $23.98
  • PTY N/A
  • Revenue Next Year
  • TNDM $10.89
  • PTY N/A
  • P/E Ratio
  • TNDM N/A
  • PTY N/A
  • Revenue Growth
  • TNDM 10.75
  • PTY N/A
  • 52 Week Low
  • TNDM $21.85
  • PTY $11.92
  • 52 Week High
  • TNDM $53.69
  • PTY $14.88
  • Technical
  • Relative Strength Index (RSI)
  • TNDM 60.83
  • PTY 27.61
  • Support Level
  • TNDM $31.89
  • PTY $14.51
  • Resistance Level
  • TNDM $34.48
  • PTY $14.85
  • Average True Range (ATR)
  • TNDM 1.80
  • PTY 0.11
  • MACD
  • TNDM 0.40
  • PTY -0.06
  • Stochastic Oscillator
  • TNDM 94.21
  • PTY 28.38

Stock Price Comparison Chart: TNDM vs PTY

TNDM
PTY
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober020406080100120140160TNDM VS PTY

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use